Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
- Status
- RECRUITING
- Phase
- PHASE1
A Study of HS-20110 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of ZL-1310 in Participants With Selected Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PumaRx Registry Trial
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of SHR-4375 in Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Ensartinib in the Treatment of ALK Positive or MET Exon 14 Skipping Anvanced Solid Tumors Excluded Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults
- Status
- RECRUITING
- Phase
- PHASE2
TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A